Breaking News Instant updates and real-time market news.

CRM

Salesforce

$92.50

0.74 (0.81%)

, MSFT

Microsoft

$72.15

-0.34 (-0.47%)

11:56
08/22/17
08/22
11:56
08/22/17
11:56

On The Fly: What to watch in Salesforce earnings report

Salesforce (CRM) is scheduled to report results of its second fiscal quarter after the market close on Tuesday, August 22, with a conference call scheduled for 5:00 pm ET. What to watch for: 1. GUIDANCE: Along with its Q1 report in May, Salesforce raised its fiscal year 2018 revenue view to $10.25B-$10.3B from $10.15B-$10.2B and its FY18 adjusted EPS view to $1.28-$1.30 from $1.27-$1.29. Consensus, which stood at $10.19B and $1.29 for revenue and earnings at that time has edged up to $10.19B and $1.30, respectively, per share. 2. MICROSOFT COMPETITION: On April 24, Microsoft (MSFT) announced new integrations between its "Dynamics 365" CRM and ERP business software and LinkedIn, which it said "will help salespeople deliver better outcomes using insights from LinkedIn Sales Navigator and LinkedIn's 500M professionals." According to Reuters, the improvements to Microsoft's Dynamics 365 are a challenge to market leader Salesforce and are the first major product initiative to spring from the former's acquisition of LinkedIn. 3. WALL STREET CONFIDENCE: Over the last week, several Wall Street analysts have made bullish comments about Salesforce ahead of the company's quarterly report. Piper Jaffray analyst Alex Zukin said his channel checks indicate Salesforce had another solid quarter and he expects to see low 20% billings growth and a "typical conservative" implied low teens billings guidance for Q3. Similarly, RBC Capital analyst Ross MacMillan said he believes that Salesforce's Q2 billings growth will beat expectations, and he predicts that it will raise its full-year revenue growth guidance. He said he is upbeat on the company's fundamentals. SunTrust analyst Terry Tillman also said he expects Salesforce's Q2 results to beat expectations "based on well-balanced growth across (its) Sales, Service, Marketing and Platform businesses." Tillman thinks the company will perform well in the second half of 2018 due to seasonal billings strength, a number of "Event driven catalysts" including its Dreamforce conference, and the increased monetization of its "newer cloud products." In addition, BTIG analyst Joel Fishbein, Jr said his checks with Salesforce's partners have convinced him that the company's Q2 results will beat expectations. The analyst said checks indicate that the company has a strong pipeline and stable pricing, and is benefiting from more "multi-cloud deployments and deeper penetration of the installed base."

CRM

Salesforce

$92.50

0.74 (0.81%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

  • 22

    Aug

  • 05

    Sep

CRM Salesforce
$92.50

0.74 (0.81%)

08/22/17
ROTH
08/22/17
NO CHANGE
Target $112
ROTH
Buy
Salesforce price target raised to $112 from $103 at Roth Capital
Roth Capital analyst Richard Baldry raised his price target for Salesforce to $112 from $103 saying earnings comparisons are set to improve materially in Q2 and 2H18. The analyst reiterates a Buy rating on the shares.
08/22/17
BTIG
08/22/17
NO CHANGE
BTIG
Salesforce Q2 results likely to beat expectations, says BTIG
BTIG analyst Joel Fishbein, Jr says his checks with Salesforce's partners have convinced him that the company's Q2 results will beat expectations. The analyst says checks indicate that the company has a strong pipeline and stable pricing, and is benefiting from more "multi-cloud deployments and deeper penetration of the installed base." The analyst says the all of the company's "segments continue to show strength," while its ARPU continues to rise. He keeps a $100 price target and a Buy rating on the shares.
08/21/17
RHCO
08/21/17
NO CHANGE
RHCO
Salesforce Q2 results likely to beat expectations, says SunTrust
SunTrust analyst Terry Tillman expects Salesforce's Q2 results to beat expectations "based on well-balanced growth across (its) Sales, Service, Marketing and Platform businesses." Tillman thinks that the company will perform well in 2H18 due to seasonal billings strength, a number of "Event driven catalysts" including its Dreamforce conference, and the increased monetization of its "newer cloud products." He expects the company's fiscal 2019 results to significantly beat expectations and expects the stock to perform well in the second half of this year. He keeps a $110 price target and a Buy rating on the shares.
08/18/17
RBCM
08/18/17
NO CHANGE
RBCM
Salesforce billings growth can beat expectations, says RBC Capital
RBC Capital analyst Ross MacMillan believes that Salesforce's Q2 billings growth will beat expectations, and he preidtcs that it will raise its full-year revenue growth guidance. The analyst is upbeat on the company's fundamentals and keeps an Outperform rating.
MSFT Microsoft
$72.15

-0.34 (-0.47%)

08/07/17
FBCO
08/07/17
NO CHANGE
Target $84
FBCO
Outperform
Microsoft new accounting standards to have little impact, says Credit Suisse
Credit Suisse analyst Michael Nemeroff notes that Microsoft recently hosted a conference call to discuss its new reporting standards to reflect ASC 606 and ASC 842, which will be in effect starting with Q1 results. The analyst estimates little to no impact to his 2018 and 2019 estimates given this accounting update. However, there is higher volatility in quarterly revenue with different seasonality patterns throughout the year versus the prior standard, he adds. Nemeroff reiterates an Outperform rating and $84 price target on the shares.
07/28/17
DBAB
07/28/17
DOWNGRADE
Target $180
DBAB
Hold
MicroStrategy downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Karl Keirstead downgraded MicroStrategy (MSTR) to Hold and cut his price target for the shares to $180 from $220 citing the "disappointing" Q2 results as well as the company's strategy shift. Last night's results marked the third consecutive quarter of license revenue declines, Keirstead tells investors in post-earnings research note. MicroStrategy is now pivoting to a "much more aggressive" spending strategy in response to competition from Tableau (DATA) and Microsoft (MSFT), the analyst adds. He believes the stock has more downside risk.
07/21/17
RAJA
07/21/17
NO CHANGE
Target $84
RAJA
Strong Buy
Microsoft price target raised to $84 from $77 at Raymond James
Raymond James analyst Michael Turits raised Microsoft's price target to $84 and reiterated his Strong Buy rating following the across-the-board Q4 beat on strong commercial bookings and cloud results. The analyst trimmed FY18 and FY19 earnings on the down margin guidance and higher taxes but expects margin expansion in FY19 as cloud margins continue to rise.
07/21/17
STFL
07/21/17
NO CHANGE
STFL
Microsoft should be bought on any weakness, says Stifel
Stifel analyst Brad Reback says that Microsoft reported "strong" Q4 results, as he noted that the growth of its cloud business, Azure, accelerated to 98% year-over-year, while its commercial bookings surged 30% year-over-year. He expects the company's operating profit and free cash flow to accelerate in coming quarters and raised his price target to $80 from $73 while keeping a Buy rating. .

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

11:20
09/25/17
09/25
11:20
09/25/17
11:20
Periodicals
Amazon acquires '4 Blocks', Deadline Hollywood reports »

Amazon Prime Video…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

11:20
09/25/17
09/25
11:20
09/25/17
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

AAPL

Apple

$151.89

-1.5 (-0.98%)

11:18
09/25/17
09/25
11:18
09/25/17
11:18
Recommendations
Apple analyst commentary  »

Apple iPhone X preorder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

$NSD

NASDAQ Market Internals

11:17
09/25/17
09/25
11:17
09/25/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$151.89

-1.5 (-0.98%)

11:16
09/25/17
09/25
11:16
09/25/17
11:16
Periodicals
Apple's iPhone 8 shows slower adoption than previous models, Localytics reports »

The iPhone 8 and iPhone 8…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

$NYE

NYSE Market Internals

11:16
09/25/17
09/25
11:16
09/25/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
09/25/17
09/25
11:15
09/25/17
11:15
General news
U.S. equities were dented by N. Korean remarks »

U.S. equities were dented…

11:15
09/25/17
09/25
11:15
09/25/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
09/25/17
09/25
11:15
09/25/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

UN

Unilever; also tag UL

$58.67

0.06 (0.10%)

, UL

Unilever; also tag UN

$57.57

0.13 (0.23%)

11:10
09/25/17
09/25
11:10
09/25/17
11:10
Hot Stocks
Unilever gets into hot South Korean beauty market with acquisition »

Shares of Unilever (UN,…

UN

Unilever; also tag UL

$58.67

0.06 (0.10%)

UL

Unilever; also tag UN

$57.57

0.13 (0.23%)

GS

Goldman Sachs

$230.42

-0.61 (-0.26%)

KHC

Kraft Heinz

$77.52

-1.49 (-1.89%)

EL

Estee Lauder

$107.95

0.365 (0.34%)

LVMUY

LVMH

$55.05

0.208 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 17

    Oct

  • 22

    Oct

UPS

UPS

$117.51

-0.16 (-0.14%)

11:10
09/25/17
09/25
11:10
09/25/17
11:10
Options
Bullish longer-term play in UPS »

Bullish longer-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$95.22

-6.895 (-6.75%)

, LH

LabCorp

$150.06

-5.01 (-3.23%)

11:09
09/25/17
09/25
11:09
09/25/17
11:09
Hot Stocks
Medical diagnostics names slide after CMS proposes cuts »

Following the news of the…

DGX

Quest Diagnostics

$95.22

-6.895 (-6.75%)

LH

LabCorp

$150.06

-5.01 (-3.23%)

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

NEO

NeoGenomics

$11.01

0.09 (0.82%)

GHDX

Genomic Health

$30.98

0.13 (0.42%)

VCYT

Veracyte

$8.48

0.18 (2.17%)

VRML

Vermillion

$1.29

0.05 (4.03%)

GNMK

GenMark

$9.52

-0.04 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 30

    Nov

SPY

SPDR S&P 500 ETF Trust

$248.97

-0.47 (-0.19%)

, SPX

S&P 500

11:05
09/25/17
09/25
11:05
09/25/17
11:05
Periodicals
North Korea says firing missiles at U.S 'inevitable,' Guardian says »

According to the…

SPY

SPDR S&P 500 ETF Trust

$248.97

-0.47 (-0.19%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.24

-0.09 (-0.14%)

11:05
09/25/17
09/25
11:05
09/25/17
11:05
Options
Carnival call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

CCC

Calgon Carbon

$21.38

-0.025 (-0.12%)

11:04
09/25/17
09/25
11:04
09/25/17
11:04
Downgrade
Calgon Carbon rating change  »

Calgon Carbon downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$35.91

-0.05 (-0.14%)

11:04
09/25/17
09/25
11:04
09/25/17
11:04
Hot Stocks
SpringWorks launches with $103M in Series A funding, rights to 4 programs »

SpringWorks Therapeutics,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 18

    Oct

  • 31

    Oct

  • 08

    Nov

SPX

S&P 500

11:04
09/25/17
09/25
11:04
09/25/17
11:04
General news
North Korea says Trump's comments declaration of war, Bloomberg reports »

North Korean Foreign…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$87.60

0.15 (0.17%)

11:04
09/25/17
09/25
11:04
09/25/17
11:04
Initiation
PriceSmart initiated  »

PriceSmart initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

EBS

Emergent BioSolutions

$38.52

0.18 (0.47%)

11:02
09/25/17
09/25
11:02
09/25/17
11:02
Recommendations
Emergent BioSolutions analyst commentary  »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AIR

AAR Corp.

$37.17

0.23 (0.62%)

10:58
09/25/17
09/25
10:58
09/25/17
10:58
Hot Stocks
AAR Corp. to provide airframe maintenance for Air Canada fleet »

AAR and Air Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBNT

Ubiquiti

$54.18

1.52 (2.89%)

10:57
09/25/17
09/25
10:57
09/25/17
10:57
Periodicals
Citron publishes new report on Ubiquiti Networks »

After Citron Research…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

WFC

Wells Fargo

$54.21

-0.0369 (-0.07%)

10:55
09/25/17
09/25
10:55
09/25/17
10:55
Options
Wells Fargo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

GPC

Genuine Parts

$93.73

5.745 (6.53%)

10:55
09/25/17
09/25
10:55
09/25/17
10:55
Conference/Events
Genuine Parts to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

  • 30

    Oct

SSRM

SSR Mining

$10.26

0.16 (1.58%)

10:52
09/25/17
09/25
10:52
09/25/17
10:52
Upgrade
SSR Mining rating change  »

SSR Mining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$41.13

0.24 (0.59%)

, SCOR

comScore

$29.10

0.25 (0.87%)

10:50
09/25/17
09/25
10:50
09/25/17
10:50
Periodicals
Nielsen sues comScore to prevent Extended TV service, Reuters reports »

Nielsen Holdings (NLSN)…

NLSN

Nielsen

$41.13

0.24 (0.59%)

SCOR

comScore

$29.10

0.25 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.